메뉴 건너뛰기
소속 기관 / 학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
고객센터 ENG
주제분류

논문 기본 정보

저자정보
출처
Wiley VIEW 6(5)
오류 신고하기
표지

검색

    초록·키워드

    Abstract Fibroblast activation protein (FAP), highly expressed in activated fibroblasts within injured myocardium, serves as the molecular target for FAP inhibitor (FAPI)‐based imaging. Among developed radiopharmaceuticals, 68 Ga‐FAPI and 18 F‐FAPI demonstrate rapid target‐tissue accumulation and low background signals, yielding superior imaging characteristics. While FAPI positron emission tomography (PET) is widely used in oncology, its cardiac applications are emerging. This review examines the role of FAPI imaging across major cardiac conditions—including myocardial infarction, hypertrophic cardiomyopathy, dilated cardiomyopathy, and cardiac amyloidosis—and critically evaluates its diagnostic performance against established modalities (e.g., fluorodeoxyglucose (FDG) PET, cardiac magnetic resonance imaging [MRI]). We further discuss technical considerations, limitations, and future directions for optimizing FAPI‐based cardiovascular molecular imaging, highlighting its potential to advance early diagnosis, risk stratification, and therapeutic monitoring in cardiac diseases.

    본문·목차

    최근 본 자료 전체보기